RHYTHM PHARMACEUTICALS, INC. (RYTM) /

The profitability of RHYTHM PHARMACEUTICALS, INC. over the past 10 years

Chart RHYTHM PHARMACEUTICALS, INC.: gross profit, operating income, net income, fiscal 2016–2025 Open the chart →

RHYTHM PHARMACEUTICALS, INC. reported a net loss of $196.54M in fiscal 2025, the latest fiscal year on file. That year it had gross profit of $170.26M and an operating loss of $192.02M. It reported a loss in all 10 years shown.

Year by year

Fiscal yearGross profitOperating incomeNet income
2025ended Dec 31, 2025$170.26M*-$192.02M-$196.54M
2024ended Dec 31, 2024$116.76M*-$265.5M-$260.6M
2023ended Dec 31, 2023$68.13M*-$184.36M-$184.68M
2022ended Dec 31, 2022$21.5M*-$179.16M-$181.12M
2021ended Dec 31, 2021$2.56M*-$170.06M-$69.61M
2020ended Dec 31, 2020—-$136.57M-$134M
2019ended Dec 31, 2019—-$146M-$140.73M
2018ended Dec 31, 2018—-$78.42M-$74.06M
2017ended Dec 31, 2017—-$32.41M-$33.71M
2016ended Dec 31, 2016—-$25.91M-$25.87M

Fiscal years as RHYTHM PHARMACEUTICALS, INC. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.

More on RHYTHM PHARMACEUTICALS, INC.

Companies of a similar size

Not investment advice. This page shows what RHYTHM PHARMACEUTICALS, INC. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.